These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16026004)

  • 1. Regional intestinal absorption and biliary excretion of fluvastatin in the rat: possible involvement of mrp2.
    Lindahl A; Sjöberg A; Bredberg U; Toreson H; Ungell AL; Lennernäs H
    Mol Pharm; 2004; 1(5):347-56. PubMed ID: 16026004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration- and region-dependent intestinal permeability of fluvastatin in the rat.
    Lindahl A; Sandström R; Ungell AL; Lennernäs H
    J Pharm Pharmacol; 1998 Jul; 50(7):737-44. PubMed ID: 9720622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of fluvastatin, an inhibitor of HMG-COA reductase, in mouse, rat, dog, and monkey.
    Tse FL; Smith HT; Ballard FH; Nicoletti J
    Biopharm Drug Dispos; 1990; 11(6):519-31. PubMed ID: 2207302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
    Dahan A; Sabit H; Amidon GL
    Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface activity and concentration dependent intestinal permeability in the rat.
    Lindahl A; Persson B; Ungell AL; Lennernäs H
    Pharm Res; 1999 Jan; 16(1):97-102. PubMed ID: 9950286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of [3H]fluvastatin following single oral doses in beagle dogs and rhesus monkeys with bile fistulae.
    Tse FL; Dain JG; Kalafsky G
    Biopharm Drug Dispos; 1995 Apr; 16(3):211-9. PubMed ID: 7787133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic drug interaction between fexofenadine and fluvastatin mediated by organic anion-transporting polypeptides in rats.
    Qiang F; Lee BJ; Lee W; Han HK
    Eur J Pharm Sci; 2009 Jun; 37(3-4):413-7. PubMed ID: 19428223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of fluvastatin.
    Scripture CD; Pieper JA
    Clin Pharmacokinet; 2001; 40(4):263-81. PubMed ID: 11368292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
    Dahan A; Amidon GL
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional intestinal permeability in rats of compounds with different physicochemical properties and transport mechanisms.
    Fagerholm U; Lindahl A; Lennernäs H
    J Pharm Pharmacol; 1997 Jul; 49(7):687-90. PubMed ID: 9255712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jejunal permeability and hepatic extraction of fluvastatin in humans.
    Lindahl A; Sandström R; Ungell AL; Abrahamsson B; Knutson TW; Knutson L; Lennernäs H
    Clin Pharmacol Ther; 1996 Nov; 60(5):493-503. PubMed ID: 8941022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state pharmacokinetics of fluvastatin in healthy subjects following a new extended release fluvastatin tablet, Lescol XL.
    Barilla D; Prasad P; Hubert M; Gumbhir-Shah K
    Biopharm Drug Dispos; 2004 Mar; 25(2):51-9. PubMed ID: 14872552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The difference in pharmacokinetics and pharmacodynamics between extended-release fluvastatin and immediate-release fluvastatin in healthy Chinese subjects.
    Xu HR; Chen WL; Chu NN; Li XN; Zhu JR
    J Biomed Biotechnol; 2012; 2012():386230. PubMed ID: 22811596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers.
    Tse FL; Jaffe JM; Troendle A
    J Clin Pharmacol; 1992 Jul; 32(7):630-8. PubMed ID: 1640002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption and disposition of fluvastatin, an inhibitor of HMG-CoA reductase, in the rabbit.
    Tse FL; Labbadia D
    Biopharm Drug Dispos; 1992 May; 13(4):285-94. PubMed ID: 1600114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of fluvastatin and specific drug interactions.
    Smith HT; Jokubaitis LA; Troendle AJ; Hwang DS; Robinson WT
    Am J Hypertens; 1993 Nov; 6(11 Pt 2):375S-382S. PubMed ID: 8297546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific bidirectional efflux of 2,4-dinitrophenyl-S-glutathione, a substrate of multidrug resistance-associated proteins, in rat intestine and Caco-2 cells.
    Yokooji T; Murakami T; Yumoto R; Nagai J; Takano M
    J Pharm Pharmacol; 2007 Apr; 59(4):513-20. PubMed ID: 17430634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-of-intake (morning versus evening) of extended-release fluvastatin in hyperlipemic patients is without influence on the pharmacodynamics (mevalonic acid excretion) and pharmacokinetics.
    Fauler G; Abletshauser C; Erwa W; Löser R; Witschital K; März W
    Int J Clin Pharmacol Ther; 2007 Jun; 45(6):328-34. PubMed ID: 17595890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, tolerability, and pharmacokinetics of an extended-release formulation of fluvastatin administered once daily to patients with primary hypercholesterolemia.
    Sabia H; Prasad P; Smith HT; Stoltz RR; Rothenberg P
    J Cardiovasc Pharmacol; 2001 May; 37(5):502-11. PubMed ID: 11336101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular uptake of fluvastatin, an inhibitor of HMG-CoA reductase, by rat cultured hepatocytes and human aortic endothelial cells.
    Ohtawa M; Masuda N; Akasaka I; Nakashima A; Ochiai K; Moriyasu M
    Br J Clin Pharmacol; 1999 Apr; 47(4):383-9. PubMed ID: 10233202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.